Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Curr Opin Nephrol Hypertens. 2022 Dec 23;32(2):134–140. doi: 10.1097/MNH.0000000000000866

FIGURE 2.

FIGURE 2.

Preclinical and clinical investigations showing that Sortilin drives arterial hypertension. (a) Sortilin induces hypertension through a mechanism that involves sphingosine-1-phosphate (S1P) lysosphingolipid receptor 3 and/or gp91phox/NOX2. (b) Circulating Sortilin levels are greater in hypertensive patients with noncontrolled hypertension and correlate with S1P levels.